Bharat Biotech, WHO To Meet Today For Global Emergency Listing Of Covaxin

As of now only seven vaccines have been given EULs by WHO, including the AstraZeneca-Oxford University shot produced and sold in India as Covishield

Bharat Biotech and the World Health Organization will hold a 'pre-submission' meeting today for international emergency use listing (EUL) of Covaxin, its COVID-19 vaccine. The meeting will give the company a chance to receive guidance from WHO authorities before the final submission. Last month Bharat Biotech said it had already submitted 90 per cent of the required paperwork. The Hyderabad-based manufacturer also said it was confident of getting the nod "given its experience of getting its other vaccines pre-qualified by WHO". The vaccine is 77.8 per cent effective in protecting against COVID-19, according to data studied and recommended yesterday by the national drug regulator's Subject Expert Committee. What Is An EUL?